We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
+5.99%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$18.1B
AUM Growth
+$394M
Cap. Flow
-$436M
Cap. Flow %
-2.4%
Top 10 Hldgs %
31.58%
Holding
679
New
107
Increased
219
Reduced
170
Closed
105

Sector Composition

Rank Sector Weight
1 Technology 29.51%
2 Healthcare 16.94%
3 Industrials 9.58%
4 Consumer Staples 8.15%
5 Communication Services 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BPOP icon
451
Popular Inc
BPOP
$11B
$334K ﹤0.01%
8,000
+2,500
+45% +$99.1K
MTD icon
452
Mettler-Toledo International
MTD
$26.8B
$330K ﹤0.01%
560
-6
-1% -$3.29K
PNK
453
DELISTED
Pinnacle Entertainment Inc.
PNK
$326K ﹤0.01%
16,500
+3,700
+29% +$74.3K
CRL icon
454
Charles River Laboratories
CRL
$10.9B
$324K ﹤0.01%
3,200
+700
+28% +$64.4K
MUSA icon
455
Murphy USA
MUSA
$11.3B
$324K ﹤0.01%
4,374
-62,266
-93% -$4.36M
CNA icon
456
CNA Financial
CNA
$14.5B
$322K ﹤0.01%
6,600
+1,500
+29% +$68.6K
B
457
DELISTED
Barnes Group Inc.
B
$322K ﹤0.01%
5,500
+1,000
+22% +$55.2K
TSE
458
DELISTED
Trinseo
TSE
$316K ﹤0.01%
4,600
+100
+2% +$6.54K
BAC icon
459
Bank of America
BAC
$435B
$315K ﹤0.01%
13,000
+1,000
+8% +$23.3K
PAG icon
460
Penske Automotive Group
PAG
$14.3B
$312K ﹤0.01%
7,100
+2,500
+54% +$110K
DGX icon
461
Quest Diagnostics
DGX
$25.1B
$311K ﹤0.01%
2,800
+100
+4% +$10.6K
UTHR icon
462
United Therapeutics
UTHR
$26.3B
$311K ﹤0.01%
2,400
+900
+60% +$112K
IPG
463
DELISTED
Interpublic Group of Companies
IPG
$310K ﹤0.01%
12,600
-1,600
-11% -$39.1K
RRD
464
DELISTED
RR Donnelley & Sons Co.
RRD
$308K ﹤0.01%
+24,600
New +$303K
PRAH
465
DELISTED
PRA Health Sciences, Inc.
PRAH
$308K ﹤0.01%
4,100
+300
+8% +$20.8K
CNDT icon
466
Conduent
CNDT
$230M
$307K ﹤0.01%
19,260
+2,780
+17% +$45.5K
FTI icon
467
TechnipFMC
FTI
$30.6B
$306K ﹤0.01%
15,209
-2,779
-15% -$62.7K
SKYW icon
468
Skywest
SKYW
$4.11B
$302K ﹤0.01%
8,600
-26,366
-75% -$926K
TDS icon
469
Telephone and Data Systems
TDS
$3.91B
$302K ﹤0.01%
10,900
+2,300
+27% +$63.2K
AAWW
470
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$302K ﹤0.01%
5,800
-100
-2% -$5.27K
MERC icon
471
Mercer International
MERC
$44.9M
$301K ﹤0.01%
+26,200
New +$303K
TIER
472
DELISTED
TIER REIT, Inc.
TIER
$298K ﹤0.01%
+16,100
New +$276K
CUDA
473
DELISTED
Barracuda Networks, Inc.
CUDA
$297K ﹤0.01%
+12,900
New +$284K
SYNH
474
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$293K ﹤0.01%
5,000
CWEN.A
475
DELISTED
Clearway Energy Class A
CWEN.A
$290K ﹤0.01%
17,000
+2,900
+21% +$49.7K

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q2 2017 Portfolio in Review

As of Q2 2017, Grantham, Mayo, Van Otterloo & Co (GMO) held 679 positions worth $18.1B, up 2.2% from $17.7B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q2 2017 filing shows 107 new, 219 increased, 170 reduced and 105 closed positions. Its largest new stake was Altaba Inc: 4,688,480 shares worth $255M. The largest sale was McDonald's, an estimated $157M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q2 2017 buy was Altaba Inc: 4,688,480 shares worth $255M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to CR Bard Inc. in Q2 2017, an estimated $108M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q2 2017 reduction was NXP Semiconductors, cutting an estimated $148M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited McDonald's in Q2 2017, selling an estimated $157M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 32% of its $18.1B portfolio in Q2 2017.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 107 new positions and closed 105 in Q2 2017.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value rose 2.2% quarter-over-quarter to $18.1B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2017, filed 14 Aug 2017.